Sage Capital Advisors’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$47.7K Sell
10,335
-10,560
-51% -$52.3K 0.01% 140
2026
Q1
$96.7K Sell
20,895
-815
-4% -$4.25K 0.02% 129
2025
Q4
$109K Sell
21,710
-9,572
-31% -$49.8K 0.03% 128
2025
Q3
$159K Buy
31,282
+815
+3% +$3.59K 0.04% 130
2025
Q2
$131K Buy
30,467
+11,143
+58% +$55.1K 0.03% 133
2025
Q1
$117K Sell
19,324
-76
-0.4% -$384 0.03% 131
2024
Q4
$76.6K Buy
+19,400
New +$86.9K 0.02% 136
2024
Q3
Sell
-11,000
Closed -$47.4K 147
2024
Q2
$47.4K Buy
+11,000
New +$52.7K 0.01% 134
2023
Q2
Sell
-14,533
Closed -$119K 130
2023
Q1
$119K Buy
14,533
+25
+0.2% +$276 0.05% 126
2022
Q4
$162K Buy
+14,508
New +$169K 0.07% 125
2022
Q1
Sell
-9,231
Closed -$215K 113
2021
Q4
$215K Buy
+9,231
New +$198K 0.08% 101

Other funds holding MPT

Sage Capital Advisors's MPT Position: Q2 2026 in Review

Sage Capital Advisors reduced its Medical Properties Trust (MPT) stake by 51% in Q2 2026, selling an estimated $52.3K and leaving 10,335 shares worth $47.7K. The position accounts for 0.01% of the portfolio, ranked #140.

Sage Capital Advisors first reported a position in MPT in Q4 2021 and has held it in 11 quarters since. The position peaked at $215K in Q4 2021. 76 funds tracked by Wall St. Rank hold MPT as of Q2 2026.

  • Sage Capital Advisors held 10,335 shares of Medical Properties Trust worth $47.7K as of Q2 2026.
  • Sage Capital Advisors sold 10,560 Medical Properties Trust shares in Q2 2026, an estimated $52.3K.
  • Medical Properties Trust made up 0.01% of Sage Capital Advisors's portfolio in Q2 2026, its #140 holding.
  • Sage Capital Advisors first reported a position in Medical Properties Trust in Q4 2021 and has held it in 11 quarters since.
  • Sage Capital Advisors's Medical Properties Trust position peaked at $215K in Q4 2021.
  • 76 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2026.

Based on Sage Capital Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.